Alpenglow Biosciences CEO, Nick Reder Featured in Recent Pharma's Almanac Interview

In this recent Pharma’s Almanac interview, Alpenglow CEO Nicholas Reder, M.D. explains the critical role of pathology in understanding the safety and efficacy of drugs and how Alpenglow is using a novel combination of 3D imaging, cloud computing & AI analysis to address the limitations associated with legacy approaches.